MedTrace Logo

EVIS - Ex-vivo Assessment of T-lymphocyte Homing in Primary Pancreatic Cancer

NCT02695966 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2019-07-16

No results posted yet for this study

Summary

This is a single-centre, prospective, non-randomised research study. The research team will investigate the feasibility of assessing primary human pancreatic tissue for changes to T lymphocyte function and localisation in the presence and absence of AMD3100.

Conditions

Interventions

PROCEDURE

Whipples Surgery

Whipples Surgery

Sponsors & Collaborators

  • Cancer Research UK Cambridge Institute

    collaborator OTHER

  • University of Cambridge

    collaborator OTHER

  • Cambridge University Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • James Dr Thaventhiran · University of Cambridge

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2018-07-31
Completion
2018-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02695966 on ClinicalTrials.gov